Detailed description page of ThPDB2
| This page displays user query in tabular form. |
16243 details |
| Primary information | |
|---|---|
| ID | 16243 |
| Therapeutic ID | Th1756 |
| Protein Name | ACY001 |
| Sequence | NA |
| Molecular Weight | NA |
| Chemical Formula | NA |
| Isoelectric Point | NA |
| Hydrophobicity | NA |
| Melting point | NA |
| Half-life | NA |
| Description | 0 |
| Indication/Disease | Investigated for use/treatment in cardiac ischemia and cardiovascular disorders. |
| Pharmacodynamics | NA |
| Mechanism of Action | Hemangioblasts are stem cells which can differentiate into hematopoietic cells (blood cells)and angiogenic (blood vessel endothelium forming) cells. These cells are being investigated for use in repairing damaged cardiac tissue and preventing the deteriation of the retina in diabetic retinopathy. |
| Toxicity | NA |
| Metabolism | NA |
| Absorption | NA |
| NA | |
| Clearance | NA |
| Categories | NA |
| Patents Number | NA |
| Date of Issue | NA |
| Date of Expiry | NA |
| Drug Interaction | NA |
| Target | NA |
| Brand Name | NA |
| Company | NA |
| Brand Description | NA |
| Prescribed For | NA |
| Chemical Name | NA |
| Formulation | NA |
| Physical Appearance | NA |
| Route of Administration | NA |
| Recommended Dosage | NA |
| Contraindication | NA |
| Side Effects | NA |
| Useful Link 1 | Link |
| Useful Link 2 | NA |
| Remarks | NA |